-
Details
-
Written by Pampareddy B. Kollur, Satish B. Biradar, Sangappa V. Kashinakunti, Gurupadappa S. Kallaganada, Manjula R., Jagadish B. Ingin
-
Parent Category: Year 2012, Volume 4
-
Category: Year 2012, Volume 4, Issue 2, May-August 2012
-
Hits: 4461
Introduction: Smoking is a major risk factor in the genesis of coronary atherosclerosis and development of coronary heart disease. Smoking may alter normal plasma lipoprotein levels. The present study was undertaken to compare the lipid profile between non- smokers (Group A) and chronic smokers (Group B) and also between chronic smokers (Group B) and chronic smokers with acute myocardial infarction (AMI) (Group C).
Methods: Thirty six apparently healthy non- smokers, 36 apparently healthy chronic smokers and 36 chronic smokers with AMI were selected for the study. Fasting venous blood samples were collected; triglycerides (TG), total cholesterol (TC) and high density lipoprotein cholesterol (HDL-C) were measured. Low-density lipoprotein cholesterol (LDL-C) and very low-density lipoprotein cholesterol (VLDL-C) were calculated by Friedwald’s formula.
Results: The lipid profile was compared between Group A and Group B and also between Group B and Group C. There was a significant rise in TG, TC, LDL-C, VLDL-C and significant decrease in HDL-C in Group B compared to Group A. There was a significant rise in TG, TC, LDL-C, VLDL-C and significant decrease in HDL-C in Group C compared to Group B.
Conclusion: Smoking increases the risk of atherosis and smoking modulates the ischemic heart disease risk through gene-environment interaction. Further studies are required to ascertain the gene environment interaction.
Key words: Non-smokers; Chronic smokers; Acute myocardial infarction; Lipid profile
Nike React ElementAir Jordan 1 Dark Mocha 555088-105 2020 Release Date
The most recent editorial (June 2021)
Ethics of Publishing Case Reports: Do We Need Ethics Approval and Patient Consent?
An editorial by Dr. Mehrdad Jalalian
Read more.
The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.
To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here
Our previous editorial (June 2020)
Lessons from COVID-19 pandemic and the Morocco’s success story.
An editorial by Dr. Benksim Abdelhafid (Morocco)
Read more.
The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.
The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:
TDR Clinical Research and Development Fellowships
Call for applications
Deadline for submission: 7 March 2019, 16:00 (GMT)
TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:
Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019
Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).
About the Instructor
Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more:
